Evidence map›Paper›PMID 34077733›Full record

ArticleCell reports2021

An acquired acyltransferase promotes Klebsiella pneumoniae ST258 respiratory infection.

Danielle Ahn, Gitanjali Bhushan, Thomas H McConville, Medini K Annavajhala, Rajesh Kumar Soni, Tania Wong Fok Lung, Casey E Hofstaedter, Shivang S Shah, Alexander M Chong, Victor G Castano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. AnResearch square · 2026
    Article
  2. Article
  3. Decoding Host-Pathogen Dynamics inAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Lipid A modification of colistin-resistantInfection and immunity · 2024
    Article
  9. Article
  10. Influence of NMolecules (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Immunometabolic control byImmunometabolism (Cobham, Surrey) · 2023
    Review
  15. Oral Administration ofMicroorganisms · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Danielle AhnDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: dsa2120@cumc.columbia.edu.
Gitanjali BhushanDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Thomas H McConvilleDepartment of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Medini K AnnavajhalaDepartment of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Rajesh Kumar SoniProteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
Tania Wong Fok LungDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Casey E HofstaedterDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, Baltimore, MD 21201, USA.
Shivang S ShahDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Alexander M ChongDepartment of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Victor G CastanoDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, Baltimore, MD 21201, USA.
Anne-Catrin UhlemannDepartment of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Alice PrinceDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
Columbia University Irving Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Innate Immune Clearance of Host-Adapted Pulmonary PathogensR35HL135800 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2017 to 2023
$5.9M
Carbapenem-resistant bacterial colonization and infection after liver transplantR01AI116939 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI UHLEMANN, ANNE-CATRIN · 2015 to 2019
$2.4M
MS Diagnostic Bacterial Identification LibraryR01AI147314 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2020 to 2024
$2.3M
Columbia Integrated Training Program in Infectious Diseases ResearchT32AI100852 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK, Anne-Catrin Uhlemann · 2013 to 2026
$2.2M
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural VariantsR01AI123820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2016 to 2019
$1.5M
Elucidating the genotypic determinants and phenotypic effects of polymyxin resistance in Klebsiella pneumoniae utilizing CRISPR-Cas9K08AI146284 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MCCONVILLE, THOMAS HOWE · 2020 to 2024
$962k
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infectionK08HL138289 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AHN, DANIELLE · 2017 to 2021
$734k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCI NIH HHS P30 CA013696NCRR NIH HHS S10 RR027050NHLBI NIH HHS K08 HL138289NHLBI NIH HHS R35 HL135800NIAID NIH HHS K08 AI146284NIAID NIH HHS R01 AI116939NIAID NIH HHS R01 AI123820NIAID NIH HHS R01 AI147314NIAID NIH HHS T32 AI100852
6 · The paper itself

Abstract

Klebsiella pneumoniae ST258 is a human pathogen associated with poor outcomes worldwide. We identify a member of the acyltransferase superfamily 3 (atf3), enriched within the ST258 clade, that provides a major competitive advantage for the proliferation of these organisms in vivo. Comparison of a wild-type ST258 strain (KP35) and a Δatf3 isogenic mutant generated by CRISPR-Cas9 targeting reveals greater NADH:ubiquinone oxidoreductase transcription and ATP generation, fueled by increased glycolysis. The acquisition of atf3 induces changes in the bacterial acetylome, promoting lysine acetylation of multiple proteins involved in central metabolism, specifically Zwf (glucose-6 phosphate dehydrogenase). The atf3-mediated metabolic boost leads to greater consumption of glucose in the host airway and increased bacterial burden in the lung, independent of cytokine levels and immune cell recruitment. Acquisition of this acyltransferase enhances fitness of a K. pneumoniae ST258 isolate and may contribute to the success of this clonal complex as a healthcare-associated pathogen.

Indexed as

AcetylationAcyltransferasesAnimalsBacterial ProteinsCarbapenemsCitric Acid CycleGene DeletionGlucoseGlycolysisKlebsiella InfectionsKlebsiella pneumoniaeLipid ALungLysineMaleMetabolomeAcyltransferasesBacterial ProteinsCarbapenemsGlucoseLipid ALysineacetylationbacterial pneumoniaglycolysisKlebsiella pneumoniaemetabolismsequence type 258

Identifiers

PMID34077733
PMCPMC8283688
OpenAlexW3164533471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.